Have a personal or library account? Click to login
May the FORS be with you: a system sequel Cover

May the FORS be with you: a system sequel

By: A.K. Hult and  M.L. Olsson  
Paid access
|Feb 2021

References

  1. Hult AK, Olsson ML. The FORS awakens: review of a blood group system reborn. Immunohematology 2017;33:64–72.
  2. Brito S, Hesse C, Mendes F. FORS, a new histo-blood group: a current review. Med Res Innov 2017;1:1–5.
  3. Storry JR, Castilho L, Daniels G, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012). Vox Sang 2014;107:90–6.
  4. Svensson L, Hult AK, Stamps R, et al. Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system. Blood 2013;121:1459–68.
  5. Forssman J. Die Herstellung hochwertiger spezifisher Schafhämolysin ohne Verwendung von Schaftblut: Ein Beitrag Zur Lehre von heterolofer Antikörperbildung. Biochem Zeit 1911;37:78–115.
  6. Yamamoto M, Cid E, Yamamoto F. Molecular genetic basis of the human Forssman glycolipid antigen negativity. Sci Rep 2012;2:975.
  7. Möller M, Jöud M, Storry JR, Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240–9.
  8. Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, et al. A global reference for human genetic variation. Nature 2015;526:68–74.
  9. Hult AK, McSherry E, Moller M, Olsson ML. GBGT1 is allelically diverse but dispensable in humans and naturally occurring anti-FORS1 shows an ABO-restricted pattern. Transfusion 2018;58:2036–45.
  10. Xu H, Storch T, Yu M, Elliott SP, Haslam DB. Characterization of the human Forssman synthetase gene: an evolving association between glycolipid synthesis and host-microbial interactions. J Biol Chem 1999;274:29390–8.
  11. Abusibaa WA, Srour MA, Moslemi AR, et al. Expression of the GBGT1 gene and the Forssman antigen in red blood cells in a Palestinian population. Transfus Med Hemother 2019 2019;46:450–4.
  12. Frame T, Carroll T, Korchagina E, Bovin N, Henry S. Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007;47:876–82.
  13. Jesus C, Hesse C, Rocha C, et al. Prevalence of antibodies to a new histo-blood system: the FORS system. Blood Transfus 2018;16:178–83.
  14. Barone A, Benktander J, Whiddon C, et al. Glycosphingolipids of porcine, bovine, and equine pericardia as potential immune targets in bioprosthetic heart valve grafts. Xenotransplantation 2018;25:e12406.
  15. Yamamoto F. Evolutionary divergence of the ABO and GBGT1 genes specifying the ABO and FORS blood group systems through chromosomal rearrangements. Sci Rep 2017;7:9375.
  16. Turcot-Dubois AL, Le Moullac-Vaidye B, Despiau S, et al. Long-term evolution of the CAZY glycosyltransferase 6 (ABO) gene family from fishes to mammals: a birth-and-death evolution model. Glycobiology 2007;17:516–28.
  17. Eirin-Lopez JM, Rebordinos L, Rooney AP, Rozas J. The birth-and-death evolution of multigene families revisited. Genome Dyn 2012;7:170–96.
  18. Cid E, Yamamoto M, Yamamoto F. Blood group ABO gene-encoded A transferase catalyzes the biosynthesis of FORS1 antigen of FORS system upon Met69Thr/Ser substitution. Blood Adv 2018;2:1371–81.
  19. Yamamoto M, Cid E, Yamamoto F. ABO blood group A transferases catalyze the biosynthesis of FORS blood group FORS1 antigen upon deletion of exon 3 or 4. Blood Adv 2017;1:2756–66.
  20. Cid E, Yamamoto M, Yamamoto F. Amino acid substitutions at sugar-recognizing codons confer ABO blood group system-related alpha1,3 Gal(NAc) transferases with differential enzymatic activity. Sci Rep 2019;9:846.
  21. Yamamoto M, Tarasco MC, Cid E, Kobayashi H, Yamamoto F. ABO blood group A transferase and its codon 69 substitution enzymes synthesize FORS1 antigen of FORS blood group system. Sci Rep 2019;9:9717.
  22. Yamamoto M, Cid E, Yamamoto F. Crosstalk between ABO and Forssman (FORS) blood group systems: FORS1 antigen synthesis by ABO gene-encoded glycosyltransferases. Sci Rep 2017;7:41632.
  23. Grunnet N, Steffensen R, Bennett EP, Clausen H. Evaluation of histo-blood group ABO genotyping in a Danish population: frequency of a novel O allele defined as O2. Vox Sang 1994;67:210–5.
  24. Hakomori S, Wang SM, Young WW Jr. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with “A-like antigen” in human cancer. Proc Natl Acad Sci U S A 1977;74:3023–7.
  25. Villegas-Ruiz V, Juarez-Mendez S. Data mining for identification of molecular targets in ovarian cancer. Asian Pac J Cancer Prev 2016;17:1691–9.
  26. Szperl AM, Ricano-Ponce I, Li JK, et al. Exome sequencing in a family segregating for celiac disease. Clin Genet 2011;80:138–47.
  27. Fan L, Meng H, Guo X, Li X, Meng F. Differential gene expression profiles in peripheral blood in Northeast Chinese Han people with acute myocardial infarction. Genet Mol Biol 2018;41:59–66.
DOI: https://doi.org/10.21307/immunohematology-2020-037 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 14 - 18
Published on: Feb 17, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 A.K. Hult, M.L. Olsson, published by American National Red Cross
This work is licensed under the Creative Commons License.